Researchers at Mayo Clinic’s campus in Florida have conducted the world’s first prospective, blinded, and placebo-controlled clinical study to test the benefit of using bone marrow stem cells, a regenerative medicine therapy, to reduce arthritic pain and disability in knees.
This week’s Research Roundup highlights the presence of intraepithelial food antigen in patients with active eosinophilic oesophagitis.
This week’s Research Roundup highlights that there is no difference between latiglutenase and a placebo in reducing villous atrophy or improving symptoms in patients with symptomatic celiac disease.
Researchers at Mayo Clinic Center for Individualized Medicine have discovered a potential cause and a promising new treatment for inflammatory myofibroblastic tumors, a rare soft tissue cancer that does not respond to radiation or chemotherapy.
This week’s Research Roundup highlights common and extremely large fragile sites are targets for human papillomavirus integrations and chromosome rearrangements in oropharyngeal squamous cell carcinoma.
This week’s Research Roundup highlights chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor.
This week’s Research Roundup highlights natural history of wild-type transthyretin cardiac amyloidosis and quantitation of albumin in urine by liquid chromatography tandem mass spectrometry.
This week’s Research Roundup highlights new developments in clinical bacteriology laboratories and myocardial injury and infarction.
In a recent interview with “GenomeWeb,” Robin Patel, M.D., Director of the Infectious Diseases Research Laboratory at Mayo Clinic, described a metagenomic sequencing approach her lab is testing to identify potential infections in patients whose joint replacements fail.
This week’s Research Roundup highlights the prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment.
A team of Mayo Clinic researchers has, for the first time, successfully mapped patterns of prostate cancer recurrence, following surgery.